Jin, L., Nonaka, Y., Miyakawa, S., Fujiwara, M. & Nakamura, Y. Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain. Mol Ther. doi:10.1038/mt.2016.158 (2016).Dual the
Anti-FGF-2/basic FGF (neutralizing) Antibody, clone bFM-1 Quick View Z688282 Centrifuge tubes with attached cap Quick View Sigma-Aldrich SAB5701786 Anti-Phospho-FOXO3A-S253 antibody produced in rabbit Quick View Sigma-Aldrich SAB5701943 Anti-Phospho-FOXO3A-S425 antibody produced in rabbit Quick ...
50. Through the ERK1/2 signaling pathway, FGF dramatically reduces the levels of inflammatory factors such as IL-1, tumor necrosis factor (TNF-α), IL-6, and Monocyte chemoattractant Protein-1 (MCP-1)51. Moreover, FGF
PTH parathyroid hormone, FGF21 fibroblast growth factor 21, Gpld1 glycosylphosphatidylinositol-specific phospholipase D1, OCN osteocalcin, LCN2 lipocalin-2, CCL11 C-C motif chemokine ligand 11, B2M β2-microglobulin, GDF11 growth differentiation factor 11, TIMP2 tissue inhibitor of metalloproteinase...
FGF 2 ant-239 Mouse Anti Human Fibroblast Growth Factor Basic GH ant-197 Mouse Anti Human Growth Hormone GH ant-230 Mouse Anti Human Growth Hormone IgG2b HGH ant-036 Polyclonal Rabbit Anti Human Growth Hormone GMCSF ant-129 Mouse Anti Human Granulocyte Macrophage-Colony Stimulating Factor GCSF ...
FGF 2 ant-239 Mouse Anti Human Fibroblast Growth Factor Basic GH ant-197 Mouse Anti Human Growth Hormone GH ant-230 Mouse Anti Human Growth Hormone IgG2b HGH ant-036 Polyclonal Rabbit Anti Human Growth Hormone GMCSF ant-129 Mouse Anti Human Granulocyte Macrophage-Colony Stimulating Factor GCSF ...
2, Daniel A. Bonsor1,6, Eric J. Sundberg1,3,6, Wuyuan Lu1,2, Krishanu Ray2, Andrés Finzi4,5,7, George K. Lewis1,3 & Marzena Pazgier1,2 Antibody-dependent cell-mediated cytotoxicity (ADCC) by non-neutralizing antibodies (nnAbs) specific to the HIV envelope ...
FIG. 1 (prior art) is a schematic representation of a typical antibody. FIG. 2 is a graph summarizing results from an experiment to measure stimulation of proliferation of FGFR2-IIIb-expressing FDCP-1 cells by FGF2 (), FGF7 (∇), FGF9 (□) and FGF10 (x). FIG. 3 is a grap...
The present invention provides a method of neutralizing activation of human VEGFR2 or murine VEGFR2 comprising contacting a cell with an effective amount of an antibody or fragment of the present invention. The present invention provides a method of inhibiting angiogenesis comprising administering to a ...
91(1):153-159 (1993). Borgstrom et al., “Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy” Cancer Research 56(17):4032-4039 (1996). ...